MINNEAPOLS / ST. PAUL (March 9, 2011) – University of Minnesota researchers are using salmonella – the bacteria commonly transmitted through food that sickens thousands of U.S. residents each year – to do what was once unthinkable: help people.
U of M Masonic Cancer Center researchers believe salmonella may be a valuable tool in the fight against cancer in organs surrounding the gut – such as the liver, spleen, and colon – since that's where salmonella naturally infects the body.
Researchers want to "weaponize" salmonella, allowing the bacteria to then attack cancer cells in its natural environment.
Trials in animals have already shown salmonella can successfully controlled tumors in the gut. Human clinical trials are already underway at the U of M and are showing promise.
"Many bacteria and viruses - even harmful ones - can be used to fight disease," said Edward Greeno, M.D., lead researcher on the clinical study and Medical Director of the Masonic Cancer Clinic. "We believe it may even be possible to use bacteria to fight cancer."
Scientists have known for centuries that cancer patients sometimes get better after they've been exposed to an infection. For example, Greeno said, there is a published Austrian report from the 1860's on a patient with a large tumor. The patient was placed in the same room as another sick patient with a bad infection. Soon, the tumor became infected and began to shrink in the original patient and nearly disappeared.
Unfortunately, the infection also killed the patient with the tumor.
So the key for this research initiative, Greeno said, was to find a way to get the tumor fighting abilities of salmonella delivered to the patient - without making the patient sick.
What they came up with:
In a nutshell, by using genetically modified salmonella packaged with IL-2, Medical School researchers have created a kind of two-prong attack on cancer – the immune response called in by IL-2, and the salmonella itself. The therapy is administered simply – mixed with a few ounces of water and imbibed orally.
"This probably won't replace other ways of treating cancer such as chemotherapy and radiation," Greeno said. "But it's a promising area of study and we hope it can be a potent tool in our battle against cancer. It also has potential to be a much cheaper and less toxic alternative to chemotherapy and radiation."
The study is funded by the National Institutes of Health, the Masonic Cancer Center and Botanic Oil Innovations.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.